Showing posts with label Multiple Sclerosis. Show all posts
Showing posts with label Multiple Sclerosis. Show all posts
Thursday, November 19, 2020

FDA Approves Zeposia (ozanimod) for Relapsing Forms of Multiple Sclerosis

›
Myers Squibb Company (NYSE: BMY)  announced that the U.S. Food and Drug Administration (FDA) approved  Zeposia  (ozanimod) 0.92 mg for the t...
Tuesday, March 17, 2020

FDA Approves Vumerity (diroximel fumarate) for Multiple Sclerosis

›
 Biogen Inc. (Nasdaq: BIIB) and Alkermes plc (Nasdaq: ALKS),  announced  the U.S. Food and Drug Administration (FDA) approval of  ...
Saturday, June 8, 2019

FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis

›
In continuation of my update on  cladribine The U.S. Food and Drug Administration,    approved   Mavenclad   (cladribine) tablet...
Tuesday, June 4, 2019

FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis

›
In continuation of my update on  cladribine The U.S. Food and Drug Administration,    approved   Mavenclad   (cladribine) tablet...
Wednesday, May 15, 2019

Mavenclad Approved for Multiple Sclerosis

›
In continuation of my update on Mavenclad ( cladribine)    Mavenclad ( cladribine ) tablets have been approved by the U.S. Foo...
Tuesday, May 14, 2019

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis

›
In continuation of my update on ozanimod Celgene Corporation (NASDAQ:CELG)  announced that the Company has submitted a New Drug Ap...
Friday, April 26, 2019

FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis

›
In continuation of my update on Cladribine The U.S. Food and Drug Administration,  approved Mavenclad (cladribine) tablets to ...
Thursday, March 28, 2019

Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis

›
    Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB)  announced that the U.S. Food and Drug Administration (FDA) has accepte...
Tuesday, July 4, 2017

TSRI scientists shed light on molecular workings of MS drug

›
In continuation of my update on Tecfidera A study by scientists at The Scripps Research Institute (TSRI) has helped to de-mystify th...
Wednesday, July 6, 2016

New plant-derived oral drug can prevent progression of multiple sclerosis

›
    An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis...
1 comment: